NYSE - Delayed Quote USD

Biohaven Ltd. (BHVN)

16.02
+0.20
+(1.26%)
At close: May 16 at 4:00:02 PM EDT
16.02
0.00
(0.00%)
After hours: May 16 at 7:17:01 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
923,432
885,111
436,051
567,932
218,900
Operating Income
-923,432
-885,111
-436,051
-567,932
-218,900
Other Income Expense
35,612
39,424
26,500
-1,909
6,470
Pretax Income
-887,820
-845,687
-409,551
-569,841
-212,430
Tax Provision
775
735
-1,383
438
1,366
Net Income Common Stockholders
-888,595
-846,422
-408,168
-570,279
-213,796
Diluted NI Available to Com Stockholders
-888,595
-846,422
-408,168
-570,279
-213,796
Basic EPS
-9.25
-9.28
-5.73
-12.75
-5.97
Diluted EPS
-9.25
-9.28
-5.73
-12.75
-5.97
Basic Average Shares
96,319.73
91,234.34
71,200.53
44,741.32
35,822.51
Diluted Average Shares
96,319.73
91,234.34
71,200.53
44,741.32
35,822.51
Total Operating Income as Reported
-923,432
-885,111
-436,051
-567,932
-218,900
Total Expenses
923,432
885,111
436,051
567,932
218,900
Net Income from Continuing & Discontinued Operation
-888,595
-846,422
-408,168
-570,279
-213,796
Normalized Income
-888,595
-846,422
-408,168
-570,279
-213,796
EBIT
-923,432
-885,111
-436,051
-567,932
-218,900
EBITDA
-914,777
-877,256
-429,139
-566,546
-217,507
Reconciled Depreciation
8,655
7,855
6,912
1,386
1,393
Net Income from Continuing Operation Net Minority Interest
-888,595
-846,422
-408,168
-570,279
-213,796
Normalized EBITDA
-914,777
-877,256
-429,139
-566,546
-217,507
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 9/23/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CYTK Cytokinetics, Incorporated
31.00
+3.89%
 
TVTX Travere Therapeutics, Inc.
16.80
-20.57%
 
BBIO BridgeBio Pharma, Inc.
33.84
+0.30%
 
SRRK Scholar Rock Holding Corporation
30.55
-0.91%
 
XENE Xenon Pharmaceuticals Inc.
30.29
+2.43%
 
URGN UroGen Pharma Ltd.
7.31
-25.79%
 
AKRO Akero Therapeutics, Inc.
38.87
-2.73%
 
APLS Apellis Pharmaceuticals, Inc.
17.45
+6.66%
 
RCKT Rocket Pharmaceuticals, Inc.
6.50
-3.35%
 
SRPT Sarepta Therapeutics, Inc.
36.43
+3.29%